Source: Anticancer Research. Unidade: FMVZ
Subjects: CÃES, NEOPLASIAS EM ANIMAL, NEOPLASIAS MAMÁRIAS, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Maria Isabel et al. Assessing the interleukin 35 immunoexpression in malignant canine mammary tumors: association with clinicopathological parameters and prognosis. Anticancer Research, v. 39, n. 4, p. 2077-2083, 2019Tradução . . Disponível em: https://doi.org/10.21873/anticanres.13319. Acesso em: 28 abr. 2024.APA
Carvalho, M. I., Pires, I., Prada, J., Pinto, C., Gregório, H., Cogliati, B., & Queiroga, F. L. (2019). Assessing the interleukin 35 immunoexpression in malignant canine mammary tumors: association with clinicopathological parameters and prognosis. Anticancer Research, 39( 4), 2077-2083. doi:10.21873/anticanres.13319NLM
Carvalho MI, Pires I, Prada J, Pinto C, Gregório H, Cogliati B, Queiroga FL. Assessing the interleukin 35 immunoexpression in malignant canine mammary tumors: association with clinicopathological parameters and prognosis [Internet]. Anticancer Research. 2019 ; 39( 4): 2077-2083.[citado 2024 abr. 28 ] Available from: https://doi.org/10.21873/anticanres.13319Vancouver
Carvalho MI, Pires I, Prada J, Pinto C, Gregório H, Cogliati B, Queiroga FL. Assessing the interleukin 35 immunoexpression in malignant canine mammary tumors: association with clinicopathological parameters and prognosis [Internet]. Anticancer Research. 2019 ; 39( 4): 2077-2083.[citado 2024 abr. 28 ] Available from: https://doi.org/10.21873/anticanres.13319
